SNMMI
@SNM_MI
Followers
8K
Following
1K
Media
2K
Statuses
6K
An international scientific and medical organization dedicated to raising public awareness about molecular imaging. Visit us at https://t.co/5hokaFcg4x
Reston, Virginia
Joined October 2009
Are you a NMT student curious about what it’s like to work in the field? Join us on December 10th for the Student & Recent Graduate Q&A Webinar, a conversation where current students can hear from working technologists.
0
0
1
Lantheus and the SNMMI-TS are thrilled to provide five $10,000 Entry Level Nuclear Medicine Technology Scholarships! Funded by @LantheusNews, these scholarships will support individuals interested in pursuing a career as a nuclear medicine technologist. https://t.co/bpeCmoMAnv
0
0
4
Being able to personalize a patient's treatment is one of the cornerstones of nuclear medicine, but how are we able to do that? PET-Guided radiotherapy is one answer. Learn more about when to use it in Episode 14 of the JNM Podcast: https://t.co/D7ahVchQSD
0
0
2
UCLA launches "first of its kind" new standalone Department of Nuclear Medicine and Theranostics. @UCLAHealth @SNM_MI
radiologybusiness.com
“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman.
0
3
3
This $10,000 grant is designed to provide critical funding to early-to-mid career researchers in nuclear medicine, radiochemistry, and medical physics. Submission deadline is December 1, 2025 https://t.co/TuvGxTr6pK
0
0
0
FREE for members! This webinar is designed to correlate currently available evidence and complex clinical scenarios, with a special emphasis on the role multidisciplinary discussion. Register now! https://t.co/lj3FVGqBgt
0
0
1
Prostate Cancer Grant: Deadline December 1, 2025! This grant was created for innovative research addressing unmet medical needs in the diagnosis and treatment of prostate cancer. This three-year grant and will provide $75,000 per year. Apply Now: https://t.co/FHx2qJDpz6
0
0
0
Looking for the photos from this year's Theranostics Conference? They're now posted on the SNMMI Flickr site! View the entire album here: https://t.co/lyGNpJbEoI
0
0
4
A 100% Complete Response Rate Shows Promise--85% of mice also achieved histologic cure. 1 and 2-cycle treatments were equally effective and well-tolerated. In the patient xenograft, a single 225Ac treatment achieved a 60% response and prolonged survival compared to no treatment.
0
0
2
Though previous studies have shown that HER2-targeted radiotherapies with the alpha-particle-emitting radionuclide 225Ac were effective, they were not safe for patients, as 225Ac was retained in the body, causing high toxicity.
1
1
3
Pre-treating a tumor before delivering alpha-radioimmunotherapy has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer. https://t.co/jJc4UfBn65
1
2
2
So happy that you were in attendance to share your perspective!
0
1
4
Hearing from Jud, a patient who was diagnosed with neuroendoctine tumors, about his experience in the NETTR-2 trial and RLT therapy.
1
1
5